Logo.png
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
July 02, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 02, 2024 (GLOBE NEWSWIRE) -- Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin,...
Emergen logo.png
Atopic Dermatitis Drugs Market Size Worth USD 25.20 Billion in 2032 | Emergen Research
December 28, 2023 08:04 ET | Emergen Research
Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market size was USD 6.10 Billion in 2022 and is expected to register a rapid revenue CAGR of 15.2% during the forecast...
Transparency Market Research
Atopic Dermatitis Drugs Market Size to Surpass USD 28.2 billion by 2031, at a CAGR of 8.9% | Transparency Market Research Inc.
October 16, 2023 12:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global atopic dermatitis drugs market is likely to develop at an 8.9% CAGR from 2023 to...
Transparency Market Research
Atopic Dermatitis Drugs Market to Grow at a CAGR of 14.7% from 2022 to 2031, reaching USD 29.4 Billion: As per TMR Study
July 31, 2023 11:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market stood at US$ 6.0 billion in 2021, and the global market is projected to reach US$...
Logo.png
Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
December 05, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Atopic...